To determine whether type I IFN and autoantibodies could be implicated in disease activity within specific organ systems, we examined the association between SLE-associated autoantibodies, IFN-inducible chemokines, and C3 as well as the presence of individual SLE pathologies. The gene discussed is C3; the disease is systemic lupus erythematosus.